Slide 1

Michael De Vito M.D. Capital Region Otolaryngology Group Albany, Troy, Clifton Park and Hudson Slide 2 Introduction Sinusitis: Affects 30 million individuals per year in the US 90% of patients will see their primary care physician Accounts for 11.6 million visits to primary care physicians annually Accounts for 9% of pediatric and 21% of adult antibiotic prescription s Slide 3 Anatomy Slide 4 Slide 5 Sinus Drainage Pathways Slide 6 Pathogenesis of Sinusitis Slide 7 Classification of Sinusitis Sinusitis is defined as an inflammation of the mucous membrane that lines the paranasal sinuses It is classified chronologically as: Acute Recurrent Acute Subacute Chronic Acute Exacerbation of Chronic Slide 8 Acute Rhinosinusitis A New Infection That May Last Up To Four Weeks Can Be Subdivided Symptomatically Into Severe Non-severe Slide 9 Recurrent Acute Rhinosinusitis Four or More Separate Episodes of Acute Sinusitis That Occur Within One Year Slide 10 Subacute Rhinosinusitis An Infection That Lasts Between Four to Twelve Weeks Usually Represents a Transition From Acute To Chronic Infection Slide 11 Chronic Rhinosinusitis When Signs and Symptoms Last for More Than Twelve Weeks Slide 12 Diagnosis of Sinusitis Slide 13 Viral Versus Bacterial Rhinosinusitis Viral Upper Respiratory Illnesses Occur: 3-8 per year in children 2-3 per year in adults Gwaltney: (1996,1994) Found 90% of CT Scans Showed Evidence of Sinus Involvement With Viral Rhinosinusitis Slide 14 Viral Upper Respiratory Infection Course Slide 15 Viral Versus Bacterial Rhinosinusitis Difficult to Differentiate Symptoms of Bacterial Sinusitis Worsen After Five Days Bacterial Infections Persist For At Least Ten Days Task Force On Rhinosinusitis Of The AAO-HNS Diagnosis of Acute Sinusitis Depended On The Presence of : Two Major Diagnostic Factors or One Major Factor and Two Minor Factors Slide 16 Diagnostic Predictive Factors of Sinusitis Slide 17 Slide 18 Acute Sinusitis Definitions Slide 19 Radiographic Imaging Radiographic Imaging Should Not Be Used In Patients That Meet The Diagnostic Criteria of Acute Rhinosinusitis Exceptions Include: A Potential Complication of Sinusitis An Alternative Diagnosis is Suspected Slide 20 Symptomatic Treatment Analgesics and Antipyretics for Pain and Fever Topical or Systemic Decongestants for Symptomatic Relief Neither have been proven to prevent a URI from becoming ABRS Topical Better Than Systemic for Congestion Relief 3 Day Maximum Longer Rebound Concern Systemic Steroids Have Shown No Effectiveness Antihistamines Have No Studies As To Effectiveness Slide 21 Symptomatic Treatment Topical Steroid Sprays Have Shown Some Benefit Industry studies and included antibiotics Nasal Saline for Quality of Life Improvement Decrease medication use for frequent ABRS Guaifenesin Insufficient evidence Slide 22 Most Prevalent Pathogens in Adult Sinusitis 1.Sinus and Allergy Partnership. Otolaryngol Head Neck Surg 2004. 2.AAOHNS. Otolaryngol Head Neck Surg. 2007. Streptococcus pneumoniae (20-43%) Haemophilus influenzae (22-35%) Streptococcus spp. (3-9%) Anaerobes (0-9%) Moraxella catarrhalis (2-10%) Staphylococcus aureus (0-8%) Other (4%) Slide 23 Empiric Treatment in Children Amoxocillin-clavulanate Rather Than Amoxocillin Increasing prevalence of H. influenza in URIs in children High prevalence of Beta-lactamase producing pathogens in ABRS H. influenza and Moraxella catarrhalis IDSA 2012 Clinical Practice Guidelines for Acute Rhinosinusitis Slide 24 Antibiotic Regimen in Children Slide 25 Starting Empiric Antibiotic Treatment In Adults When Clinical Diagnosis Has Been Established By The Guidelines Symptoms of rhinosinusits lasting more than 10 days Severe symptoms or high fever and purulent nasal discharge or facial pain lasting 3-4 consecutive days at the onset of illness Worsening of symptoms with fever, headache or increased nasal discharge at day 5-6 of a URI that were improving. IDSA 2012 Clinical Practice Guidelines for Acute Rhinosinusitis Slide 26 Antibiotic Regimen for Adults Slide 27 Treatment of Penicillin Allergic Patients Skin Testing to Confirm of Exclude Immediate Hypersensitivity Adults: Respiratory Floroquinolone (Levofloxacin,Moxifloxacin) Doxycycline Macrolides or TMP/SMX No Longer Recommended because of increased resistance of S. pneumonia and H. influenza Slide 28 Children with Penicillin Allergy Children with Type 1 Hypersensitivity: Levofloxacin FDA approved for use only after Anthrax Exposure 2523 Children Studied in the Pediatric Levaquin Study (Noel, 2007) Well tolerated after 12 Months But Musculoskeletal Events 1.9% vs..79% at 2 months 2.9% vs.1.6% at 12 months Probably Warranted with Type 1 sensitivity Slide 29 Children with Non-Type 1 Third Generation Oral Cephalosporin: Cefixime, Cefpodoxime In Combination With Clindamycin Slide 30 Duration of Therapy 5-7 Days Seems Appropriate Most patients studied by sinus puncture had symptomatic improvement and bacteriological eradication within 72 hours of initiation of treatment Treatment beyond 10 days for acute, uncomplicated patients seems excessive Children Should Be Treated for 10-14 Days Studies still lacking to recommend less Slide 31 Nonresponsive Patients Patients Who Clinically Worsen After 72 Hours or Fail to Improve After 3-5 Days of Empiric Therapy: Resistant Pathogens Noninfectious Etiology Structural Abnormalities CT of MRI Noninfectious causes of suppurative complications Sinus or Meatal Cultures Careful Clinical Assessment Slide 32 Sinus Cultures Direct Sinus Aspiration : Most Accurate but Invasive, Not Well Tolerated Middle Meatal Cultures: Benninger (2006) 81% sensitivity, 91% specificity, 83% predictive value Nasopharyngeal Swabs: Unreliable Slide 33 Allergy Evaluation Chronic Sinusitis And Allergy: 40-80% of Adults 25-31% Young Adults Should Be Considered In: Chronic Rhinosinusitis Recurrent Acute Rhinosinusitis Skin Testing As The Preferred Testing Method Slide 34 Immunodeficiency Patients with Chronic Rhinosinusits or Recurrent Acute Sinusitis Failure of Aggressive Medical Therapy or Persistent Purulent Infection Most Common Disorders: Selective IgA Deficiency Hypogammaglobulinemia IgG Subclass Deficiency is Unclear HIV Patients ( 30-68%) Slide 35 Slide 36 Fungal Sinusitis Mycetoma Fungal Sinusitis Fungus Ball Usually in the Maxillary Sinus Treatment is Surgical Removal of the Lining Allergic Fungal Sinusitis An Allergic Reaction to Environmental Fungi Immunocompetent Host Thick Fungi and Mucin Accumulate Surgical Removal of the Allergen(Fungi) Slide 37 Fungal Sinusitis Chronic Indolent Sinusitis Generally outside the U.S. (Sudan, India) No Immune Deficiency Progresses from Month to Years Characterized by a Granulomatous Inflammatory Infiltrate Slide 38 Fulminant Fungal Sinusitis Immunocompromised Patients Immunodefeciency Disorders (Diabetes) Immunosuppressive Agents Can Result in Progressive Destruction of the Sinuses with Resulting Invasion of the Eye or Cranial Cavity Mucormycosis a common fungi Slide 39 Sinus Headache Clinical History: Primary Complaint is Headache Without Significant Nasal Symptoms Migraine Headache Embedded In Other Bothersome Nasal Symptoms Evaluation of Nasal and Sinus Cavities Warranted Headache is a Minimal or Inconspicuous Complaint Rhinosinustis May Be Likely Slide 40 Sinus Headache Physical Exam: Nasal Exam Findings Which May Suggest Secondary Pathology: Inflammatory Changes (Allergy) Anatomic Abnormalities Purulent Nasal Discharge Testing: Imaging Can Be Useful False Positive Results Slide 41 Sinus Headaches Sinus Disease As A Cause of Headache Has Been Ingrained Into The American Public Little Evidence to Support This Migraine Can Present With Facial Pain, Nasal Congestion and Rhinorrhea. In Clinical Studies Nearly 90% With Self-Diagnosed or Physician Diagnosed Sinus Headache Met The Criteria for IHS Migraine-Type Headaches. Most Responded To Triptan Interventions Slide 42 Sinus Headaches Slide 43 Specialist Referral Slide 44 Treatment 90% of Patients Can Be Treated and Cured of Sinusitis With Medical Therapy Surgical Treatment: For the Treatment of Anatomic Obstruction (Polyps,Septal Deviations) Recurrent Acute Infections CRS Non-Responsive To Medial Therapy Slide 45 Surgical Treatment Functions Endoscopic Sinus Surgery (FESS): All done through the nose Removal of Abnormal and Obstructive Tissue To Restore the Normal Drainage Pathways of the Sinuses Results in Removal of Less Normal Tissue Can Be Done as an Outpatient Slide 46 Surgical Treatment Image Guided Surgery Three Dimensional View of the Surgical Field For Severe Cases or Patients Who Have Had Prior Surgery Requires a Planning CT Slide 47 BALLOON SINUPLASTY Slide 48 Questions?